"At the new, 86,000 square foot Asplundh Cancer Pavilion, our cancer specialists will have access to all the tools they need to provide top-tier care under one roof, to people living with cancer and their families."

During the past decade, Asplundh Cancer Pavilion conducted 48 clinical trials. In the 10-year time frame, 48 clinical trials started and 1 clinical trials were completed, i.e. on average, 2.1% percent of trials that started reached the finish line to date. In the past 5 years, 22 clinical trials started and 1 clinical trials were completed. i.e. 4.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Asplundh Cancer Pavilion" #1 sponsor was "National Cancer Institute (NCI)" with 27 trials, followed by "NRG Oncology" with 11 trials sponsored, "Alliance for Clinical Trials in Oncology" with 3 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 2 trials sponsored and "GOG Foundation" with 2 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Asplundh Cancer Pavilion" #1 collaborator was "National Cancer Institute (NCI)" with 23 trials as a collaborator, "NRG Oncology" with 14 trials as a collaborator, "Canadian Cancer Trials Group" with 5 trials as a collaborator, "Alliance for Clinical Trials in Oncology" with 1 trials as a collaborator and "Cancer Prevention Pharmaceuticals, Inc." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Asplundh Cancer Pavilion" are "Recurrent Ovarian Carcinoma" (4 trials), "Cervical Adenocarcinoma" (3 trials), "Cervical Adenosquamous Carcinoma" (3 trials), "Mucosal Melanoma" (3 trials) and "Ovarian Seromucinous Carcinoma" (3 trials). Many other conditions were trialed in "Asplundh Cancer Pavilion" in a lesser frequency.

Most popular intervention types in "Asplundh Cancer Pavilion" are "Drug" (38 trials), "Other" (34 trials), "Procedure" (27 trials), "Biological" (23 trials) and "Radiation" (18 trials). Other intervention types were less common.

The name of intervention was led by "Quality-of-Life Assessment" (19 trials), "Computed Tomography" (18 trials), "Questionnaire Administration" (16 trials), "Biospecimen Collection" (14 trials) and "Magnetic Resonance Imaging" (13 trials). Other intervention names were less common.

The vast majority of trials in "Asplundh Cancer Pavilion" are 33 trials for "All" genders, 14 trials for "Female" genders and 6 trials for "Male" genders.

Currently, there are NaN active trials in "Asplundh Cancer Pavilion". undefined are not yet recruiting, 20 are recruiting, 32 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Asplundh Cancer Pavilion, 1 suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Asplundh Cancer Pavilion, 2 "Phase 1" clinical trials were conducted, 23 "Phase 2" clinical trials and 34 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".